PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,776,000 | -35.8% | 250,000 | -17.1% | 0.04% | -65.6% |
| Q3 2021 | $8,991,000 | -82.4% | 301,714 | -79.8% | 0.13% | -60.4% |
| Q2 2021 | $51,004,000 | +107.7% | 1,493,114 | +100.0% | 0.33% | +6.4% |
| Q1 2021 | $24,554,000 | -54.9% | 746,557 | -15.7% | 0.31% | -46.8% |
| Q4 2020 | $54,471,000 | +153.4% | 885,556 | +46.2% | 0.58% | +86.3% |
| Q3 2020 | $21,497,000 | – | 605,556 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |